Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00906516
Title Neuradiab Combined With Bevacizumab (Avastin) Therapy in Patients With Recurrent Glioblastoma Multiforme
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bradmer Pharmaceuticals Inc.
Indications

glioblastoma

malignant astrocytoma

Therapies

81C6 + Bevacizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.